TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

Joseph Solomkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.